Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner

Annual Revenue (¥)

Shanghai Junshi Biosciences revenue was ¥3.76 b in FY, 2021

FY, 2018FY, 2019FY, 2020FY, 2021
Revenue¥684 k¥766.83 m¥1.5 b¥3.76 b

Revenue Breakdown

Business Segment

Shanghai Junshi Biosciences revenue breakdown by business segment: 11.0% from ANTITUMOR DRUGS and 89.0% from TECHNOLOGY LICENSING INCOME

FY, 2018FY, 2021FY, 2019FY, 2020
ANTITUMOR DRUGS¥411.69 k¥1 m
TECHNOLOGY LICENSING INCOME¥3.34 m¥405.1 k
BIOTECHNOLOGY¥958
SERVICE INDUSTRY OTHER DIV'E¥7
TECHNICAL SERVICES¥934

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu